Dexamethasone release pattern via a three-dimensional system for effective bone regeneration.

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Drug Delivery Systems

Background:

• Dexamethasone (DEX) has been utilized for over a decade for bone regeneration and anti-inflammatory effects.
• Its osteoinductive properties are valuable in vitro, but cytotoxicity at higher concentrations limits clinical application.
• Targeted and controlled local delivery is essential to mitigate adverse effects and optimize therapeutic efficacy.

Purpose of the Study:

• To review the advantages of three-dimensional (3D) approaches over traditional two-dimensional (2D) methods for assessing dexamethasone activity and dosage.
• To examine advancements and challenges in biomaterial-based delivery systems for controlled dexamethasone release in bone regeneration.
• To explore future biomaterial strategies for efficient dexamethasone delivery in bone repair.

Main Methods:

• Review of existing literature on dexamethasone's role in bone regeneration.
• Comparison of 2D versus 3D culture models for evaluating drug efficacy and dosage.
• Analysis of current biomaterial-based drug delivery systems for controlled pharmaceutical release.

Main Results:

• Three-dimensional (3D) models offer a more relevant milieu for assessing dexamethasone (DEX) activity and dosage compared to 2D cultures.
• Biomaterial-based delivery systems are crucial for controlled DEX release, enhancing bone repair efficacy.
• Current advancements focus on optimizing drug release kinetics and minimizing cytotoxicity.

Conclusions:

• A shift towards 3D approaches is critical for accurate assessment and effective application of DEX in bone regeneration.
• Biomaterial innovations are key to developing targeted and controlled DEX delivery systems.
• Future research should focus on novel biomaterial strategies for enhanced DEX delivery and improved bone healing outcomes.